Article
Waf-1 (p21) and p53 polymorphisms in breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jan 2002
Keshava Channa, Frye Bonnie L, Wolff Mary S, McCanlies Erin C, Weston Ainsley
Abstract excerpt
p53 is a transcription factor for Waf-1/p21, a cyclin-dependent kinase inhibitor. Certain polymorphic variants of Waf-1 and p53 have been evaluated for their association with cancer risk. Previous studies indicated that certain p53 polymorphisms confer an increased risk of breast cancer [odds ratios (ORs) and 95% confidence intervals (CIs) = 2.9, 1.4-6.3 Carcinogenesis (Lond.), 17: 1313, 1996; 2.5, 1.3-4.8 Cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
